0000899243-20-007242.txt : 20200305
0000899243-20-007242.hdr.sgml : 20200305
20200305175340
ACCESSION NUMBER: 0000899243-20-007242
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200303
FILED AS OF DATE: 20200305
DATE AS OF CHANGE: 20200305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RYAN THOMAS F JR
CENTRAL INDEX KEY: 0001263366
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 20691955
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-03
0
0000730272
REPLIGEN CORP
RGEN
0001263366
RYAN THOMAS F JR
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
1
0
0
0
Common Stock
2020-03-03
4
S
0
2225
85.72
D
1923
D
Common Stock
2020-03-04
4
M
0
1992
41.19
A
3915
D
Common Stock
2020-03-04
4
M
0
2804
42.07
A
6719
D
Common Stock
2020-03-04
4
S
0
4796
88.82
D
1923
D
Stock Option (Right to Buy)
41.19
2020-03-04
4
M
0
1992
0.00
D
2025-05-21
Common Stock
1992
0
D
Stock Option (Right to Buy)
42.07
2020-03-04
4
M
0
2804
0.00
D
2028-05-16
Common Stock
2804
500
D
$85.72 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.51 to $85.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$88.82 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.51 to $89.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
This option is currently exercisable.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2020-03-05